| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B | $10.8B | $11.1B | $11.7B | $11.2B | $2.6B | $2.4B | $2.4B |
| Cost of Revenue | $8.2B | $8.1B | $8.4B | $8.8B | $7.9B | $7.1B | $7.3B | $7.1B |
| Gross Profit | $2.6B | $2.7B | $2.7B | $2.9B | $3.3B | $0.7B | $0.6B | $0.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.1B | $2.0B | $2.1B | $2.0B | $1.9B | $1.8B | $1.8B | $1.7B |
| Operating Income | $0.5B | $0.7B | $-0.3B | $0.2B | $1.3B | $0.6B | $0.8B | $1.1B |
| Net Income | $0.4B | $0.5B | $-0.4B | $0.0B | $1.0B | $0.2B | $0.3B | $0.2B |
| EPS (Basic) | $5.96 | $8.18 | $-6.90 | $0.40 | $15.01 | $3.50 | $3.69 | $3.07 |
| EPS (Diluted) | $5.93 | $8.14 | $-6.90 | $0.39 | $14.94 | $3.49 | $3.68 | $3.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.7B | $12.8B | $13.6B | $14.1B | $14.2B | $14.3B | $13.4B | $13.1B |
| Current Assets | $6.0B | $5.5B | $5.6B | $5.9B | $5.2B | $5.4B | $4.4B | $4.5B |
| Cash & Equivalents | $0.9B | $0.7B | $0.6B | $0.5B | $0.3B | $0.8B | $0.1B | $0.1B |
| Total Liabilities | $5.3B | $5.2B | $5.9B | $6.1B | $5.8B | $5.8B | $5.3B | $5.7B |
| Current Liabilities | $2.7B | $2.7B | $3.1B | $3.1B | $2.9B | $2.4B | $2.7B | $3.3B |
| Stockholders' Equity | $8.4B | $7.6B | $7.6B | $8.0B | $8.4B | $8.5B | $8.1B | $7.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.3B | $0.7B | $1.3B | $1.8B | $1.4B | $1.2B |
| Investing Cash Flow | $-0.4B | $-0.5B | $-1.0B | $-0.6B | $-0.6B | $-1.0B | $-0.6B | $-1.3B |
| Capital Expenditures | $0.4B | $0.5B | $0.6B | $0.6B | $0.7B | $0.4B | $0.5B | $0.8B |
| Financing Cash Flow | $-0.5B | $-0.6B | $-0.2B | $0.2B | $-1.2B | $-0.2B | $-0.8B | $0.2B |